Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
 
Sponsors and Collaborators
C. Babis Andreadis
University of California, San Francisco
Novartis
 
Contact
Paula Fiermonte
415-885-7605
 
Glenna Auerback
415-476-9608
 
Investigator
Charalambos Andreadis, M.D.
University of California, San Francisco
 
ClinicalTrials.gov Identifier